Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bulat Tanja M."'
Autor:
Keta Otilija D., Bulat Tanja M., Korićanac Lela B., Žakula Jelena J., Cuttone Giacomo, Privitera Giuseppe, Petrović Ivan M., Ristić-Fira Aleksandra M.
Publikováno v:
Nuclear Technology and Radiation Protection, Vol 29, Iss 3, Pp 233-241 (2014)
Molecular targeted cancer therapy is a promising treatment strategy. Considering the central role of the epidermal growth factor receptor in cell proliferation and survival, there are indications that targeted agents like tyrosine kinase inhibitor
Externí odkaz:
https://doaj.org/article/2a44314506694d96be6efba04864e9db
Autor:
Bulat, Tanja M.
Publikováno v:
Универзитет у Београду
Functional proteomics represent an approach which could provide answers to two major questions: the revelation of biological functions of unknown proteins and the description of cellular mechanisms at the protein level. The Spanish slug, Arion vulgar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=nardusnacion::8751f6350ee9a8bfa3a9d799a8c136b2
http://nardus.mpn.gov.rs/bitstream/id/29382/Disertacija.pdf
http://nardus.mpn.gov.rs/bitstream/id/29382/Disertacija.pdf
Autor:
Subotički, Tijana, Mitrović-Ajtić, Olivera, Beleslin-Čokić, Bojana B., Nienhold, Ronny, Diklić, Miloš, Đikić, Dragoslava, Leković, Danijela, Bulat, Tanja M., Marković, Dragana, Gotić, Mirjana, Noguchi, Constance T., Schechter, Alan N., Skoda, Radek C., Čokić, Vladan
Publikováno v:
Molecular Carcinogenesis
Molecular carcinogenesis
Mol Carcinog
Molecular carcinogenesis
Mol Carcinog
It has been shown that angiogenesis and inflammation play an important role in development of most hematological malignancies including the myeloproliferative neoplasm (MPN). The aim of this study was to investigate and correlate the levels of key an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a0c81f42ca4d1a42005eb04b3dee47bc
http://rimi.imi.bg.ac.rs/handle/123456789/807
http://rimi.imi.bg.ac.rs/handle/123456789/807
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ristić-Fira, Aleksandra, Petrović, Ivan M., Todorović, Dragana, Korićanac, Lela, Keta, Otilija D., Bulat, Tanja M., Cirrone, Giuseppe Antonio Pablo, Romano, Francesco, Cuttone, Giacomo
Publikováno v:
Radiotherapy and Oncology
ICTR-PHE 2012 Conference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4175::422602590d6445f33954d6cb3dc7897b
https://vinar.vin.bg.ac.rs/handle/123456789/8642
https://vinar.vin.bg.ac.rs/handle/123456789/8642
Autor:
Bulat, Tanja M., Keta, Otilija D., Korićanac, Lela, Todorović, Dragana, Petrović, Ivan M., Ristić-Fira, Aleksandra
Publikováno v:
Physical chemistry 2012 : 11th international conference on fundamental and applied aspects of physical chemistry
The effects of γ-rays on the DNA level, i.e. formation of double-strand breaks and expression of p21 were studied in vitro on the human HTB 140 melanoma cells. Cells were exposed to the dose range from 2 to 16 Gy. Effects were analyzed 30 min, 2, 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4175::eeaabedde87cf27deffbaf66605a42a6
https://vinar.vin.bg.ac.rs/handle/123456789/9299
https://vinar.vin.bg.ac.rs/handle/123456789/9299
Autor:
Keta, Otilija D., Bulat, Tanja M., Korićanac, Lela, Todorović, Dragana, Privitera, G., Petrović, Ivan M., Ristić-Fira, Aleksandra
Publikováno v:
Physical chemistry 2012 : 11th international conference on fundamental and applied aspects of physical chemistry
In order to increase radio-sensitivity of human lung adenocarcinoma NCI-H1568 cells, targeted therapy drug, erlotinib was used. The impact of radiation and erlotinib on cell behaviour was analyzed using three biological endpoints. Irradiations with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4175::11df0fb5f6f0fbc699fb46dc8d71da86
https://vinar.vin.bg.ac.rs/handle/123456789/9300
https://vinar.vin.bg.ac.rs/handle/123456789/9300